The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Choosing the Best Biomanufacturing Strategy: The Value of a Multi-Pronged Approach
Webinar On Demand
Biopharma executives face a daunting number of decisions daily as they address the challenges of bringing drugs—which may be unstable and unpredictable—to market. Perhaps the most important decision is selecting the biomanufacturing strategy that is the best fit for their organization.
View this webcast to hear industry experts discuss the benefits of having a flexible, multi-pronged approach, along with the pros and cons of outsourcing versus staying in-house for biologics drug-substance manufacturing.
Author:
Barry Rosenblatt, PhD, President, SME Biotech Consulting
Dave Kenyon, PhD, Vice President, Process Sciences, Patheon